Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diabetes in the post-GWAS era.

Nature genetics - 1 Dec 2015

Polychronakos Constantin, Alriyami Maha

Abstract excerpt

Large sample sizes, high-resolution arrays and comprehensive imputation are pushing genetic fine-mapping of complex trait loci to its limits without, in most cases, pinpointing a unique variant-gene combination. Superimposing these results on sophisticated maps of functional chromatin elements promises to break this logjam, as a new study of type 2 diabetes compellingly demonstrates.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Mapping
Share to Diabetes Mellitus, Type 2
Share to Genetic Loci

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Hepatocyte Nuclear Factor 3-beta

Share to Polymorphism, Single Nucleotide

Share to Receptor, Melatonin, MT2

Source

Identifiers

PMID: 26620109
DOI: 10.1038/ng.3453

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diabetes in the post-GWAS era.PMID 26620109Read ↗

Fine-mapping of an expanded set of type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome mapsSemantic proximity Read ↗

Progress in defining the genetic contribution to type 2 diabetes susceptibility.Semantic proximity Read ↗

What will diabetes genomes tell us?Semantic proximity Read ↗

Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes.Semantic proximity Read ↗

Genetic drivers of heterogeneity in type 2 diabetes pathophysiology.Semantic proximity Read ↗

Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetesSemantic proximity Read ↗

Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine.Semantic proximity Read ↗

Genome-wide association scans for Type 2 diabetes: new insights into biology and therapy.Semantic proximity Read ↗

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes.Semantic proximity Read ↗

Genome-wide association studies (GWAS): impact on elucidating the aetiology of diabetes.Semantic proximity Read ↗

Genetic studies of diabetes following the advent of the genome-wide association study: where do we go from here?Semantic proximity Read ↗

Genomics in the post-GWAS era.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.